Paper Details
- Home
- Paper Details
Comparative cognitive effects of carbamazepine and phenytoin in healthy adults.
Author: AbneyO L, AllenM E, KingD W, LoringD W, MeadorK J, MooreE E, ZamriniE Y
Original Abstract of the Article :
We investigated neuropsychological effects of carbamazepine and phenytoin in 21 healthy adults using a randomized, double-blind, double-crossover design and treating each subject with each drug for 1 month, separated by a 1-month washout. There were neuropsychological evaluations at baseline, the en...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.1212/wnl.41.10.1537
データ提供:米国国立医学図書館(NLM)
Comparing Cognitive Effects of Carbamazepine and Phenytoin
The field of neurology is a vast and complex desert, with many mysteries still waiting to be uncovered. This study, like a skilled explorer, delves into the cognitive effects of two commonly used anticonvulsant medications: carbamazepine and phenytoin. By comparing their impact on cognitive function in healthy adults, the researchers aimed to shed light on potential differences in their neuropsychological profiles.
The researchers, like explorers navigating a challenging landscape, used a randomized, double-blind, double-crossover design to carefully assess the cognitive performance of participants under each medication. The findings, like oases in the desert, revealed subtle differences in cognitive function between the two drugs, with both medications impacting certain cognitive domains, but without any significant differences in overall cognitive impairment.
Navigating the Cognitive Landscape
This study suggests that, despite subtle differences in cognitive effects, both carbamazepine and phenytoin may lead to mild cognitive impairment. However, the researchers emphasized that these differences were not clinically significant. This information is crucial for clinicians, allowing them to navigate the complex cognitive landscape associated with anticonvulsant therapy.
Making Informed Decisions
This research serves as a guide for clinicians in the vast desert of neurology, highlighting the importance of understanding the potential cognitive effects of anticonvulsant medications. By recognizing the subtle differences between drugs and considering the individual needs of patients, clinicians can make informed decisions about treatment options.
Dr.Camel's Conclusion
This study, like a camel caravan traversing the desert of neurology, offers valuable insights into the cognitive effects of carbamazepine and phenytoin. While both drugs may cause mild cognitive impairment, the findings suggest that these differences are not clinically significant, allowing clinicians to navigate treatment decisions with greater confidence.
Date :
- Date Completed 1991-11-21
- Date Revised 2019-05-14
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.